Research Programmes

Bowel Cancer Foundation Trust Research Programmes

We partner with a number of leading clinicians, institutions and academics across New Zealand to help with research in to improve outcomes to all bowel cancer patients across New Zealand. Some examples of where we focus...
  1. Earlier screening of patients
  2. Help develop new and more effective treatments for bowel cancer
  3. Ensure patients get rehabilitated in the most effective way

Through strategic investment in targeted research, we will help deliver improvements in bowel cancer survival.

​If you would like to donate specifically to fund research projects via a bequest or grant please contact our CEO, Georgina Mason:

If you are an academic and would like to put forward a research project for funding consideration, emailing Georgina is the ideal method to kick off this process of consideration.

Below is a summary of the current Bowel Cancer Foundation Trust research programmes currently underway.

Kiwi Medical Detection Dogs

Did you know that cancers give off a specific odour that genetically trained working dogs can detect in elements such as urine, faeces, blood and breath?

A dog’s sense of smell is so strong that it can detect the equivalent of one teaspoon of sugar in two Olympic sized swimming pools of water.

Detection dogs have been used all over the world for decades to detect explosives at airports, drugs and food, track missing persons and even alert diabetic patients before their blood sugar levels fall to dangerously low levels.

We are lucky here in New Zealand we have our very own special K9 Medical Detection Charitable Trust run by the amazing Pauline Blomfield who has over 40 years experience training.

Levi - the German Shepherd helping to detect bowel cancer and save lives

Levi has come from a genetically bred working line with a dad that is a very famous police dog in Denmark.

This is Bowel Cancer Foundation Trust's very own research trial and we are blessed to have the backing of the Lindsay Foundation funding both our first and second year, along with funding support from Perpetual Guardian.

With the establishment of a new South Island training centre, a full-time professional dog handler and Levi, the trial will be undertaken by the K9 Medical Detection NZ Charitable Trust with the help of scientists, biostatisticians and oncologists at Otago University between January 2020 and January 2022.

We are proud to announce that Levi has successfully detected 97.6% of lab grown bowel cancer cells in saline solution during his first year and has dismissed 99.8% of samples that do not contain any bowel cancer cells, (December 2020).

Levi in his "training outfit"

Read the latest national media coverage on Levi's success here:

TVNZ - Breakfast


Otago Daily Times - Front page

RNZ - with Jesse Mulligan

The second year study will see Levi joined by another black German Shepherd called Weta who will also be trained and help collect data and be tested in both their ability to detect bowel cancer in urine.​

Our Bowel Cancer Foundation Trust CEO, Georgina Mason says that a successful trial could provide a ‘significant breakthrough’ as more extensive screening is ‘badly needed’ and could pave the way to thousands more early detections.

Overseas studies have found evidence of urinary biomarkers in bowel cancer patients which we’re expecting the dogs to be able to pick up in our early-stage detection trial.

Bowel Cancer is one of the most commonly diagnosed cancers in New Zealand with around 3,000 people diagnosed with it, and 1,200 dying from it, every year.

Up to 90% of people can be saved if bowel cancer is detected early enough – but the existing National Bowel Cancer Screening Programme is currently only available for 60–74-year-olds and probably won’t be available in all District Health Board areas in New Zealand until the end 2021 due to a delay from Covid-19.

Even when the screening programme is fully rolled out it is only expected to detect between 500 and 700 cases of bowel cancer a year – this age group currently only accounts for around 36% of the cases of bowel cancer which are registered annually with the Ministry of Health.

Georgina Mason was asked to be interviewed on TV One's Breakfast in late 2019. Click here to see the interview which was 6-minutes long.

Ms Mason says that more people could be saved if we can help prioritise those who need urgent treatment.

A large number of people with a positive FIT (faecal immune) test or home bowel screening test, don’t have cancer or high-risk polyps which means that this test will enable us to make better use of resources by prioritising those patients that would more likely have bowel cancer and need urgent treatment.

This early non-invasive test could also be useful for applications outside of the screening programme to exclude bowel cancer in patients who present with non- specific symptoms or who are under the age of screening and free up our struggling workforce.

We are extremely grateful to the Lindsay Foundation who have funded both the first and second year of this trial, along with support from Perpetual Guardian. Their love of animals and desire to make an impact in Health has made them all a perfect fit for our research programme.

Familial Bowel Cancer and "Prehabilitation" Research

Bowel Cancer Foundation Trust is collaborating with Auckland Health Foundation and Allied Health on two significant pieces of bowel cancer research.

Both pieces of research will be delivered under the expertise of Auckland DHB, which is the sole beneficiary of the Auckland Health Foundation. Through donations, the foundation supports projects, research and technologies for adult health services, which have the capacity to transform healthcare and the way it is delivered within Auckland DHB.

Auckland Health Foundation CEO Gwen Green is looking forward to working with the Bowel Cancer Foundation Trust to bring these world-leading research pieces to fruition.

#1. Familial Bowel Cancer Research:

The first piece of research is around familial bowel cancer. It seeks to define an individual’s bowel cancer risk by looking at their family history of the disease, determining if they carry an inherited gene mutation that increases their risk, and therefore improving treatment strategies and outcomes.

Up to 20% of people who develop bowel cancer will have a relative with the disease, and with 90% of bowel cancers preventable if caught early enough, this piece of research has the potential to deliver a breakthrough in increasing patient survival rates.

Picture of Georgina handing over the cheque, from left to right: Gwen Green, CEO - Auckland Health Foundation, National Medical Lead of the NZ Familial Gastrointestinal Service Associate Professor, Susan Parry, and Georgina Mason, CEO - BCFT.

Bowel Cancer Foundation Trust CEO/Founder Georgina Mason says it is exciting for New Zealand to lead this potentially ground-breaking research.

“We know that if detected early, bowel cancer can be successfully treated. By better understanding people’s risk of the disease, we can ensure those most at risk receive appropriate care, such as tailored advice and regular screening.”

#2. "Prehabilitation" Impacts:

The second piece of research is around bowel cancer rehabilitation, or more specifically “prehabilitation. ” This involves goal setting, exercise training and education before bowel cancer surgery.

Through initiating the earliest possible intervention, the research aims to improve and speed up the recovery of all bowel cancer patients by exploring the impact prehabilitation can have.

Evidence suggests that physical activity following a bowel cancer diagnosis improves both cancer-specific and overall survival. Further benefits could include reducing postoperative complications and increasing a patient’s motivation and engagement in post-op rehabilitation, therefore improving their quality of life.

This research will ensure we better understand the role of prehabilitation, as we ultimately work towards developing a framework for providing both pre and post-rehabilitation services for all bowel cancer patients throughout New Zealand, enabling them to participate in specially-designed pre and post-rehab programmes.

Picture of Georgina handing over the cheque, from left to right, Georgina Mason, CEO - BCFT, Joe Monkhouse - Service Clinical Director Joe - Allied Health Services and Gwen Green, CEO - Auckland Health Foundation.

Through our donors, we support research projects that benefit patients and communities, but could not be developed without external investment and generous donations like this one.

Bowel Cancer Foundation Trust is excited to collaborate with Auckland DHB clinicians, including the National Medical Lead of the NZ Familial Gastrointestinal Service Associate Professor Susan Parry and Surgical Services Director Dr Arend Merrie, who will lead these hugely important pieces of research.

Ms Mason adds:

“It is so important to shine the spotlight on this disease, which more than 3,200 New Zealanders are diagnosed with each year."
"Having the precursors to bowel cancer myself, and being treated by Auckland DHB under the care of Professor Parry and Dr Merrie, I know first-hand the importance of research to help more patients have better outcomes like mine.”
With heartfelt thanks to the Colin McGill Estate for this generous donation which has enabled us to provide this much-needed research.

Donate to support a Research initiative

If you like the Medical Detection Dog and/or the Prehabilitation initiatives, and wish to contribute, securely donating has never been easier.

Simply select the amount you wish to donate, and follow the steps to complete a donation.

Our "donation payment system" complies with the highest security requirements set out by both the banks and credit card companies.

Thank you!

Charity Achievements

Key milestones reached by Bowel Cancer Foundation Trust


Dollars distributed in the last 12 months to fund research and provide equity of care and better patient outcomes


Bowel cancer survivors rehabilitated after gruelling treatment helping to reduce cancer re-occurrence


Bowel screening kits provided to Kiwi’s who do not qualify for free public screening to detect bowel cancer early


Years we've been making a difference for bowel cancer patients in New Zealand